000 | 01869cam a22003378i 4500 | ||
---|---|---|---|
001 | 2018036936 | ||
003 | DLC | ||
005 | 20190805163713.0 | ||
008 | 180801s2018 cau b 001 0 eng | ||
010 | _a 2018036668 | ||
020 | _a9781440861895 (set : alk. paper) | ||
020 | _z9781440861901 (ebook) | ||
042 | _apcc | ||
040 |
_aDLC _beng _erda _cDLC |
||
050 | 1 | 0 |
_aR855.3 _b.M37 2018 |
082 | 0 | 0 |
_a610.28/9 _223 |
100 | 1 | _aMaschke, Karen J., | |
245 | 1 | 0 |
_aDebating modern medical technologies : _bthe politics of safety, effectiveness, and patient access / _cKaren J. Maschke and Michael K. Gusmano. |
264 | 1 |
_aSanta Barbara, California : _bABC-CLIO, LLC, _c[2018] |
|
300 |
_avii, 215 pages ; _c25 cm |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_aunmediated _bn _2rdamedia |
||
338 |
_avolume _bnc _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aEvidence, politics, and medical care technology -- Evolving public- and private-payer approaches to evidence and health technology assessment -- Mammography screening: vested interests and polarization -- When medicare said no for amyloid pet imaging -- Placing a value on cure: lessons from the new generation of hepatitis C drugs -- Avastin and the politics of accelerated approval -- The path to the clinic for stem cell and other regenerative medicine interventions -- Conclusion: the 21st century cures act and the future of health technology assessment. | |
650 | 0 |
_aMedical technology _xPolitical aspects. |
|
650 | 0 |
_aMedical technology _xSafety measures. |
|
650 | 0 |
_aMedical technology _xSocial aspects. |
|
700 | 1 | _aGusmano, Michael K., | |
776 | 0 | 8 |
_iOnline version: _aMaschke, Karen J., author. _tDebating modern medical technologies _dSanta Barbara, California : ABC-CLIO, LLC, [2018] _z9781440861901 _w(DLC) 2018036936 |
999 |
_c234104 _d234104 |